|
POTENTIAL FOR RARE LIFE-THERATENING HEPATIC VENO-OCCLUSIVE DISEASE
|
CONCOMITANT USE MAY HAVE INCREASED RISK OF CARDIAC ARRHYTHMIAS
|
PHENYTOIN ENHANCES THE DRUG METABOLISM HENCE DECREASED SERUM LEVELS HAVE BEEN OBSERVED
|
CYCLOSPORINE PLASMA LEVELS ARE INCREASED BY THE DRUG
|
CONCURRENT USE MAY ENHANCE THE POTENTIAL FOR RENAL TOXICITY, BRONCHOSPASM, AND HYPOTENSION
|
RIFAMPICIN MAY ACCELERATES METABOLISM OF THE DRUG & MAY CAUSE DECREASED PLASMA CONCENTRATION
|
GRISEOFULVIN INCREASES RATE OF METABOLISM OF THE DRUG LEADING TO REDUCED PLASMA LEVELS
|